StockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research report report published on Friday. The firm issued a hold rating on the software maker’s stock.

Separately, TD Cowen cut their price target on shares of Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a research note on Tuesday, May 28th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of Hold and an average price target of $12.00.

Veradigm Trading Down 2.5 %

Shares of Veradigm stock opened at $9.70 on Friday. Veradigm has a 52 week low of $5.01 and a 52 week high of $14.09. The firm’s 50 day moving average is $9.64 and its two-hundred day moving average is $8.69.

Hedge Funds Weigh In On Veradigm

A number of institutional investors have recently modified their holdings of the business. Innealta Capital LLC purchased a new position in Veradigm during the 2nd quarter worth $38,000. TFO Wealth Partners LLC increased its position in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after acquiring an additional 5,264 shares during the period. Meadow Creek Wealth Advisors LLC purchased a new stake in Veradigm during the 1st quarter valued at approximately $83,000. Forest Hill Capital LLC acquired a new stake in Veradigm during the 4th quarter worth approximately $210,000. Finally, Aigen Investment Management LP purchased a new position in shares of Veradigm in the 4th quarter valued at approximately $231,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.